We report to our knowledge the first case of human infection with Ophiostoma piceae. This Sporothrix schenckii-related fungus caused disseminated infection involving the lung and the brain in a patient with lymphoblastic lymphoma. The case emphasizes the significance of molecular techniques for identification of rare fungi in the clinical microbiology laboratory.
A 41-year-old gardener was admitted to the University Hospital of Ulm due to renal failure. Kidney biopsy revealed diffuse involvement of both kidneys by lymphoblastic lymphoma. Additional but asymptomatic cerebral involvement was suspected on magnetic resonance imaging (MRI) (multiple small spots with contrast enhancement). Bone marrow biopsy showed only minimal infiltration. In his past medical history, only testicular cancer 10 years ago was remarkable, which was successfully treated by semicastration and chemotherapy. After confirmation of lymphoblastic lymphoma, chemotherapy was initiated according to the German Acute Lymphoblastic Leukemia study group (GMALL 07/03) with dexamethasone, vincristine, daunorubicin, cyclophosphamide and PEG-asparaginase [study protocol available in short form from the website of the European LeukemiaNet (Hoelzer, 2006) ]. The prophylactic antimicrobial regimen consisted of levofloxacin (500 mg per day per os) and amphotericin B (30 ml per day per os), which was replaced by fluconazole (100 mg daily per os) and subsequently by voriconazole (400 mg per day per os) during induction therapy I. Twenty-eight days after start of induction therapy II (designated day 0), the patient was readmitted to the University Hospital of Ulm complaining of fever of up to 40 u C, dyspnoea and chest pain. Two non-ulcerated skin lesions with a diameter of 262 cm showing a reddened margin were detected at the former insertion sites of a central vascular catheter in the jugular region and of a bone marrow biopsy at the hip. On the day of admission, the patient had severe neutropenia (granulocytes 0.1610 9 l
21
) and the C-reactive protein level was 306 mg l
. Empirical antimicrobial therapy was started immediately with piperacillin/tazobactam (4.5 g three times daily) and clindamycin (600 mg three times daily). Computed tomography (CT) of the chest on day 2 revealed left-sided infiltrates suspicious of fungal infection (Fig. 1a) . Thus anti-infective therapy was changed from voriconazole (which had been given for a total of 43 days) to posaconazole (800 mg per day), imipenem (500 mg four times a day) and linezolid (600 mg twice daily). Bronchoscopy was performed on day 3, but bronchial fluid was negative for fungi, pathogenic bacteria and mycobacteria. Three sets of blood cultures remained sterile. On day 3, right-sided hemiparesis developed. MRI of the head was performed on day 5 and revealed a cerebral lesion of 60639 mm in size suspicious of fungal infection (Fig. 1b) . Due to stimulation with granulocyte growth factor (480 mg daily), leukocyte counts recovered markedly (.0.5610 9 neutrophils l 21 on day 4) and the patient's temperature became normal on day 8. Repeated CT scan of the chest on day 14 showed, however, a progression of the pulmonary infiltrates. Thus antifungal therapy was changed to caspofungin (first dose 70 mg on day 15, then 50 mg daily) and a CT-guided lung biopsy was performed on day 16.
In the lung biopsy, elongated yeast-like fungal structures were detected by microscopy with the calcofluor white stain (Fig. 2a) . In addition, histopathology of the biopsy specimens revealed mycelial structures by Grocott-Gomori staining, which could not be further identified due to autolysis of the specimen. After 48 h incubation at 30 u C, plenty of whitish colonies of approximately 1 mm diameter were cultured on Sabauroud dextrose agar (SDA, bioMérieux; Fig. 2b ). Microscopy of the colonies revealed elongated cells as well as mycelial structures (Fig. 2c) . The colonies developed aerial mycelial structures and darkened coloration after further incubation at room temperature ( Fig. 2d ) and microscopy revealed a predominance of septated mycelium (Fig. 2e ). Subcultures on potato glucose agar (BD) at room temperature and 30 uC confirmed the growth characteristics observed on SDA (Fig. 2f) ; however, production of mycelium at 30 u C was reduced on this agar. For a more detailed investigation of temperature tolerance, the strain was point-inoculated on oatmeal agar culture plates at room temperature in duplicate, and subjected to constant temperatures of 27, 30, 33 and 36 u C in darkness, with or without pre-incubation for 2 days at room temperature. Growth expansion was measured every second day over 1 week. Consistent growth was obtained at 27 uC. Without pre-incubation, no growth was observed at 30 u C and above. With pre-incubation, colonies reached 30 mm in 7 days at 27 u C, down to 1.5 mm at 36 u C. Colonies at 27-33 u C were cottony, while those at 36 u C were smooth. The latter colonies showed low-frequency conversion of conidia into chlamydospore-like cells, and hyphae were very thin, but no yeast phase was observed. Growth on Mycosel agar (BD) at 27 u C was not inhibited by cycloheximide. Although the morphology was not really typical, infection by a fungus closely related to Sporothrix schenckii was initially suspected. Apart from this fungus, no other fungi or bacteria were cultured from the biopsy. . For final identification, sequencing of the internal transcribed spacer (ITS) regions 1 and 2, including the 5.8S gene, the rRNA operon, as well as the partial btubulin gene, was performed using primers and protocols of De Hoog et al. (2007) . The sequences were deposited in GenBank with the accession numbers FJ230885 (ITS sequence) and FJ230886 (b-tubulin gene). Comparisons with previously published sequences from GenBank and phylogenetic analyses (maximum-likelihood, maximumparsimony and Bayesian) of the data confirmed the identity of the isolate as Ophiostoma piceae (Fig. 3) . The identification was verified at the Centraalbureau voor Schimmelcultures (CBS) and the strain was deposited in the CBS culture collection (CBS 123358).
Following the guidelines for management of sporotrichosis (Kauffman et al., 2007) , antifungal treatment was changed from caspofungin to itraconazole (400 mg daily per os) on day 36, resulting in a significant reduction of the pulmonary lesion but rapid progression of cerebral symptoms. Neurosurgical resection of the abscess was performed on day 46, and in the biopsy specimens fungal structures were observed by microscopy with calcofluor white stain that were morphologically equal to those seen microscopically in the lung biopsy (Fig. 2a) . However, the fungus was no longer detectable by culture. A Rickham reservoir was implanted, and, using this access, liposomal amphotericin B (0.01-0.3 mg daily) was instilled into the cerebral lesion, followed by significant clinical improvement. However, treatment of lymphoma was not completed due to the severe fungal infection and 6 months after first complete remission of the lymphoma a systemic relapse with bone marrow involvement was diagnosed. The patient rejected reinduction therapy and died a few weeks later. 
Discussion
To our knowledge, this is the first case of invasive fungal infection caused by an Ophiostoma species. The genus Ophiostoma is the largest of the four teleomorph (sexual) genera of the Ophiostomatales (Ascomycetes). However, for several species in the genus, only anamorph (asexual) states are known. These asexually reproducing species, although phylogenetically placed in the Ophiostoma, are classified in one of three anamorph genera: Sporothrix, Hyalorhinocladiella or Pesotum (Zipfel et al., 2006) . The majority of the approximately 160 species of Ophiostoma (including the anamorph species) are wood-inhabiting saprophytes associated with bark beetle vectors. A few of the species are serious tree pathogens. One subgroup of Ophiostoma, the so-called Ophiostoma stenoceras-S. schenckii complex ( Supplementary Fig. S1 in JMM Online), produces Sporothrix anamorphs and contains several soil-inhabiting species, including the human pathogen S. schenckii (De Beer et al., 2003a; De Meyer et al., 2008) . O. piceae, however, belongs to another subgroup of the genus, the O. piceae complex, and causes blue-stain in the sapwood of trees and logs (Harrington et al., 2001) . The complex also includes the causal agents of the notorious Dutch elm disease, Ophiostoma ulmi and Ophiostoma novo-ulmi, that wiped out millions of elm trees during the previous century in Eurasia and North America (Brasier, 1990) . All the species in the O. piceae complex have hitherto been regarded as non-pathogenic to humans. O. piceae has a global distribution, non-specific associations with many bark beetle vectors, a wide host range and occurs commonly in areas where freshly felled timber is handled and stored, or on injured or stressed trees in native forests and commercial plantations (De Beer et al., 2003b; Harrington et al., 2001; Kirisits, 2004) .
Due to the wide distribution of O. piceae in the environment, infection in humans may be acquired by several modes, including direct inoculation through trauma, and/or pulmonary inhalation of the airborne conidia of the Sporothrix anamorph. Since biopsies were not done on the skin lesions in our patient, it remains open whether these lesions represented the initial focus of infection. Due to his profession as a gardener living in a rural environment, the patient might have had an increased exposure to the fungus. Since the Ophiostoma isolate did grow significantly less well at 36 u C than at lower temperatures in the laboratory, the pathogenic potential of the isolate may be lower than that of more heat-tolerant species. However, invasive infections with high mortality in immunocompromised patients by other filamentous fungi that do not grow well or at all at 36 u C in the laboratory, like some species of the genera Chrysosporium, Mucor, Curvularia and Alternaria, are known (Morrison et al., 1993) .
Identification of O. piceae in the clinical microbiology laboratory is a challenge. Occurrence of loosely aggregated hyphae (Fig. 2e) has been described for O. piceae (Przybyl & De Hoog, 1989) and may help to differentiate this species from S. schenckii. In addition, clustered denticles as seen in S. schenckii are missing. The Ophiostoma strain showed good growth at 27 u C but proved to be temperature-sensitive in showing no growth at higher temperatures if pre-incubation at room temperature was omitted. Rudimentary, smooth colonies were obtained after 1 week at 36 u C. At this temperature, conidia were still abundant, though supported by fragile hyphae, while hyaline chlamydospore-like cells were also obtained. An unambiguous yeast phase as in S. schenckii remained absent. Molecular identification methods, such as ribosomal gene sequencing, are necessary for accurate identification of this species. Optimal treatment of patients with Ophiostoma infection is unclear, and methods for antifungal susceptibility testing as well as interpretative criteria for test results have not been validated. Due to the close relationship to S. schenckii and the comparably low MIC value for itraconazole, high-dose itraconazole therapy for 10 weeks (Gullberg et al., 1987; McGinnis et al., 2001; Van Cutsem, 1992) was chosen, resulting in improvement of the patient and partial regression of the lesions. Nevertheless, progression of the underlying disease led to the fatal outcome in the patient. Since this Ophiostoma infection developed under prophylactic treatment with voriconazole (given, however, in a therapeutical dosage of 400 mg daily), it may be discussed whether the first-line and long-term azole therapy was adequate. In vitro susceptibility testing did not reveal increased MIC values for itraconazole or voriconazole, and treatment with itraconazole showed some clinical and radiologically documented success regarding the pulmonary lesion. However, for cure of cerebral lesions caused by Ophiostoma, amphotericin B or an azole with good penetration into cerebrospinal fluid, like voriconazole, may be required. After intracerebral instillation of amphotericin B, the patient improved significantly. Nevertheless, susceptibility testing of isolates appears to be recommended since the sensitivity of S. schenckii to amphotericin B has been reported to be strain-dependent (McGinnis et al., 2001 ). According to in vitro studies, echinocandins have less activity than triazoles against S. schenckii and other dimorphic fungi (Espinel-Ingroff, 1998) and, thus, after final identification of the isolate, therapy was changed from caspofungin to an azole. In further cases, posaconazole may also be a promising antimycotic agent since it had the lowest MIC of all azoles.
In conclusion, ubiquitous fungi from the genus Ophiostoma may represent a new group of humanpathogenic fungi in immunocompromised patients. This fatal case of O. piceae infection emphasizes the significance of invasive diagnostic measures and fungal cultures followed by molecular identification of the isolates in patients with clinical suspicion of fungal infection.
